Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations

被引：0
|
作者：
Obinna I. Ekwunife
James F. O’Mahony
Andreas Gerber Grote
Christoph Mosch
Tatjana Paeck
Stefan K. Lhachimi
机构：
[1] BIPS/University of Bremen,Collaborative Research Group for Evidence
[2] Nnamdi Azikiwe University,Based Public Health, Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology
[3] Trinity College Dublin,Department of Clinical Pharmacy and Pharmacy Management
[4] University of Cologne,Centre for Health Policy and Management, School of Medicine
[5] Universität Witten/Herdecke,Institute for Health Economics and Clinical Epidemiology
[6] ZHAW,Institute for Research in Operative Medicine (IFOM)
[7] University of Bremen,Department of Health
来源：
PharmacoEconomics | 2017年 / 35卷
关键词：
Cervical Cancer; Coverage Rate; Cervical Cancer Screening; Vaccine Coverage; Cervical Cancer Prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 82
页数：17
相关论文
共 50 条
  • [31] Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines
    A. T. Newall
    M. Jit
    R. Hutubessy
    PharmacoEconomics, 2014, 32 : 525 - 531
  • [32] Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines
    Newall, A. T.
    Jit, M.
    Hutubessy, R.
    PHARMACOECONOMICS, 2014, 32 (06) : 525 - 531
  • [33] Assessing Cost-Effectiveness of HPV Vaccines with Decision Analytic Models: What Are the Distinct Challenges of Low And Middle Income Countries? A Protocol for a Systematic Review
    Ekwunife, Obinna I.
    Grote, Andreas Gerber
    Mosch, Christoph
    O'Mahony, James F.
    Lhachimi, Stefan K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 478 - 478
  • [34] Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review
    Fung, Alastair
    Horton, Susan
    Zabih, Veda
    Denburg, Avram
    Gupta, Sumit
    BMJ GLOBAL HEALTH, 2019, 4 (05):
  • [35] Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings
    Antillon, Marina
    Bilcke, Joke
    Paltiel, A. David
    Pitzer, Virginia E.
    VACCINE, 2017, 35 (27) : 3506 - 3514
  • [36] Cost-effectiveness analyses for injury prevention initiatives in low- and middle-income countries
    Scuffham, Paul A.
    INJURY PREVENTION, 2008, 14 (04) : 217 - 219
  • [37] Cost-effectiveness of Coronavirus Disease 2019 Vaccination in Low- and Middle-Income Countries
    Siedner, Mark J.
    Alba, Christopher
    Fitzmaurice, Kieran P.
    Gilbert, Rebecca F.
    Scott, Justine A.
    Shebl, Fatma M.
    Ciaranello, Andrea
    Reddy, Krishna P.
    Freedberg, Kenneth A.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11): : 1887 - 1896
  • [38] The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries
    Razavi, Homie
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (02) : 445 - 445
  • [39] Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
    Horton, Susan
    Gelband, Hellen
    Jamison, Dean
    Levin, Carol
    Nugent, Rachel
    Watkins, David
    PLOS ONE, 2017, 12 (08):
  • [40] Financing and cost-effectiveness of emergency medical services in low- and middle-income countries
    Delaney, Peter G.
    Offorjebe, Agatha
    Arudo, John
    SURGERY, 2024, 176 (04) : 1302 - 1304
12345